Allied Blenders Q1 FY27 Earnings Call — Analysis (NSE: ABDL)

Allied Blenders delivers 5.8% revenue growth and underlying margin expansion in Q1FY27 despite ₹24 Cr supply-chain hit; management reiterates mid-teens revenue guidance and 300–400 bps margin improvement targets by FY29.

31 Jul 2026 · Analysis by Alpha Inflection

The take

Q1FY27 Revenue from operations ₹984 Cr ( +5.8% YoY ) . New guidance — FY27 fy27 revenue growth mid-teens . New story: Premiumization and portfolio upgrade .

Results

Revenue ₹984 Cr +5.8% YoY; reported EBITDA ₹120 Cr flat YoY (like-for-like ₹144 Cr +21.4%); PAT ₹45 Cr -19.6% YoY (like-for-like ₹63 Cr +13.6%); gross margin 46% (+277 bps); P&A volumes +10.7% and ICONiQ White +33.8%.

Financial highlights

Guidance

FY27 revenue growth mid-teens, EBITDA margin broadly in line with FY26; backward integration to add ~300 bps margin by FY28 and further 100 bps by FY29; India-UK FTA to bring 70–80 bps margin in H2FY27 and 130–140 bps in FY28.

What management committed to

• FY27 revenue growth will be mid-teens — mid-teens, FY27
• FY27 EBITDA margin will be broadly in line with FY26 — broadly in line with FY26, FY27
• Backward integration will deliver approximately 300 basis points of EBITDA margin expansion by FY28 — 300 basis points, FY28
• An additional 100 basis points of margin expansion will be delivered by FY29 — 100 basis points, FY29
• India-UK FTA will improve margins by 70–80 basis points in FY27 (flowing in H2 FY27) — 70 to 80 basis points, FY27
• India-UK FTA will improve margins by 130–140 basis points on a full-year basis in FY28 — 130 to 140 basis points, FY28
• ICONiQ White volume will reach close to 15 million cases in FY27 — close to 15 million cases, FY27
• ABD Maestro revenue will double in FY27 from the ~₹40 Cr base in FY26 — double (~₹80 Cr), FY27
• Officer’s Choice Blue will be launched with revamped packaging in Q3 FY27 — Q3FY27
• Sterling Reserve B7 will receive new packaging in Q4 FY27 — Q4FY27
• A deluxe vodka will be launched in H2 FY27 — H2FY27
• A premium Indian whisky will be launched in H2 FY27 — H2FY27

Key themes

Premiumization-led growth and margin expansion journey

How the narrative shifted

• Premiumization and portfolio upgrade: Premiumization is the central growth driver; Prestige & Above contribution continues rising, led by ICONiQ White which is the world’s fastest-growing millionaire whisky.
• Brand reset for Officer’s Choice Blue and B7: Two legacy P&A brands are being repositioned with entirely new packaging and communication to regain salience and volume, with OC Blue in Q3 and B7 in Q4.
• Backward integration for structural margin expansion: Capex in ENA, malt, PET and bottling will be EBITDA accretive, delivering ~300 bps margin expansion by FY28 and 100 bps by FY29 while improving supply security.
• Temporary global supply chain disruption: Q1 profitability was hit by a one-off ₹24 Cr supply chain impact from geopolitical disruptions; management sees pressure peaking in Q2 and a broad recovery from Q3.
• India-UK FTA margin tailwind: The FTA is expected to add 70–80 bps to margins in H2 FY27 and 130–140 bps in FY28, supporting sourcing flexibility for the high-end portfolio.
• International expansion as a strategic growth lever: Exports are asset-light, high-margin and working-capital-efficient; the footprint has grown to 39 countries and ICONiQ White now reaches 10 international markets.
• Super-premium/luxury portfolio building (ABD Maestro): ABD Maestro, with 10 differentiated brands, is expected to double revenue in FY27 and will benefit from a dedicated execution team and expanding touchpoints.

Operational commentary

• ICONiQ White recognized as world’s fastest-growing millionaire whisky brand for 3rd consecutive year; posted 3.1 million cases in Q1 (+33.8% YoY)
• P&A segment outperformed industry: +10.7% volume growth vs industry low single-digit
• ABD Maestro super-premium/luxury portfolio expanded to 5,500+ premium touchpoints, 6 international markets and 4 travel retail locations; targeting doubling of revenue in FY27
• Malt distillery at Rangapur expected to become operational in H1 FY27, strengthening in-house malt capacity as part of backward integration
• International presence increased to 39 countries (from 36 in Q4FY26); ICONiQ White now available in 10 export markets
• Officer’s Choice Blue brand reset planned with revamped packaging in Q3 FY27; Sterling Reserve B7 new packaging rollout targeted for Q4 FY27
• White-space launches: deluxe vodka and premium Indian whisky planned for H2 FY27
• Telangana overdue ~₹400 Cr; new supply payments are being received on agreed timelines, old dues partially cleared

Analyst Q&A

• Q. Where are we on ABD Maestro luxury segment manpower, distribution, and visibility? Is cost likely to accelerate?

  We have reached ~5,500 premium outlets and will expand. Revenue was ~₹40 Cr in FY26 and is expected to double in FY27. Expenses are not going to mount further; ABD Maestro will benefit from ABD’s support in distribution.

• Q. Is the FY28 EBITDA margin guidance at risk if Telangana doesn’t grant a price hike? Are you building in a quick resolution of the global supply chain disruption?

  We have built necessary guardrails for margin delivery even without a price hike. The supply chain pressure should last only up to Q2; Q3 and Q4 will see a bounce back. The 2-year guidance remains unchanged.

• Q. Non-ICONiQ White P&A brands (Officer’s Choice Blue, B7, B10) have declined at high-teens CAGR over 3 years; what’s the exact problem?

  Cash-flow issues pre-listing are behind us. OC Blue is being relaunched with completely new packaging, new communication; B7 is due for a brand reset with a new design and packaging in H2 FY27. ICONiQ will grow to ~15 million cases this year.

• Q. Why the disconnect between your mid-teens guidance in disclosures and your comment about stepping it up to high teens?

  There is no disconnect. Our stated guidance is mid-teens; I am tempted to say further expansion could happen because of new brand launches, packaging revamp, and margin-accretive capex, but that is a personal view while we review the guidance.

View source

Research and educational content only. Not investment advice.